Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A technique for intensifying BCG sensitivity.

S R Parmett, E Klein

    Journal of Medicine
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Bacille Calmette-Guérin (BCG) sensitization is more effective at DNCB challenge sites. This finding impacts cancer immunotherapy strategies by optimizing BCG sensitization effectiveness for improved outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Generation of cytotoxicity with various MHC class I restrictions against autologous LCL by stimulating the lymphocytes with autologous and/or allogeneic LCLs sharing HLA alleles with the responder.

    Cellular immunology·1992
    Same author

    HLA-B5-restricted auto-tumor-specific cytotoxic T cells generated in mixed lymphocyte-tumor-cell culture.

    International journal of cancer·1992
    Same author

    [Urinary excretion of mineral arsenic, methylarsonic acid and dimethylarsinic acid in workers exposed to gallium arsenide].

    Journal de toxicologie clinique et experimentale·1992
    Same author

    A trypsin-like serine protease activity on activated human B cells and various B cell lines.

    European journal of immunology·1992
    Same author

    Characteristic ionic composition of endolymph is maintained in cultured inner ear.

    Acta oto-laryngologica·1992
    Same author

    MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).

    International journal of cancer·1992
    Same journal

    Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.

    Journal of medicine·2007
    Same journal

    YABA virus induced tumor in men--long term follow-up and possible bio-warfare role.

    Journal of medicine·2007
    Same journal

    Breast cancer in intraductal carcinogen-treated non-human primates.

    Journal of medicine·2007
    Same journal

    Multiple medical problems following agent orange exposure.

    Journal of medicine·2007
    Same journal

    A gastric hiatal hernia may make abdominal pain disappear.

    Journal of medicine·2007
    Same journal

    Gene expression profiles of late colonic Crohn's disease.

    Journal of medicine·2007
    See all related articles

    Area of Science:

    • Immunology
    • Dermatology
    • Cancer Research

    Background:

    • Bacille Calmette-Guérin (BCG) is an immunotherapy agent.
    • Delayed hypersensitivity reactions are immune responses.
    • 1-chloro, 2,4-dinitrobenzene (DNCB) is a chemical inducer of delayed hypersensitivity.

    Purpose of the Study:

    • To investigate the effectiveness of BCG sensitization at different challenge sites.
    • To explore the impact of delayed hypersensitivity on BCG efficacy.
    • To consider implications for cancer immunotherapy.

    Main Methods:

    • Sensitization with BCG at DNCB-induced delayed hypersensitivity sites versus unchallenged sites in animals.
    • Measurement of Purified Protein Derivative of tuberculin (PPD) 24-hour skin test intensity to assess BCG sensitization effectiveness.

    Related Experiment Videos

    Main Results:

    • BCG sensitization was significantly more effective when administered at the site of a DNCB-induced delayed hypersensitivity reaction.
    • Administration at unchallenged sites resulted in lower BCG sensitization effectiveness.
    • The PPD skin test intensity was a reliable measure of BCG sensitization efficacy.

    Conclusions:

    • The location of BCG sensitization relative to a delayed hypersensitivity reaction influences its effectiveness.
    • Optimizing BCG administration at inflammatory sites may enhance its immunotherapeutic potential.
    • This phenomenon has potential implications for improving cancer immunotherapy strategies.